1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Lung Non-Small Cell Squamous Carcinoma: new trials by email Literature Review of Lung Non-Small Cell Squamous Carcinoma trials Research Report on Lung Non-Small Cell Squamous Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) Rucaparib - Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation | Phase 2 | Completed | SWOG Cancer Research Network | 64 | 2019-04-16 | 2025-05-21 |
Adenocarcinoma of Lung (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
Adenocarcinoma (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
rucaparib (1)
SWOG Cancer Research Network (1)
United States (1)
Jonathan W Riess (1)
U10CA180888 (1)